Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer

By Sin Thomas K.   Wang Fengfeng   Meng Fei   Wong S. C. Cesar   Cho William C. S.   Siu Parco M.   Chan Lawrence W. C.   Yung Benjamin Y. M.  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 237-237

MDPI

Access to resources Recommend Favorite

Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy

By Bersanelli Melissa   Buti Sebastiano   Camisa Roberta   Brighenti Matteo   Lazzarelli Silvia   Mazza Giancarlo   Passalacqua Rodolfo  

Cancers, Vol. 6, Iss. 4, 2014-09 ,pp. : 2035-2048

MDPI

Access to resources Recommend Favorite

Melatonin Sensitizes H1975 Non-Small-Cell Lung Cancer Cells Harboring a T790M-Targeted Epidermal Growth Factor Receptor Mutation to the Tyrosine Kinase Inhibitor Gefitinib

By  

Cellular Physiology and Biochemistry, Vol. 34, Iss. 3, 2014-08 ,pp. : 865-872

Karger

Access to resources Recommend Favorite

Lentivirus‐mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro

By  

BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol. 34, Iss. 1, 2018-01 ,pp. : 196-205

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”

By Alama Angela   Coco Simona   Vanni Irene   Grossi Francesco  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1309-1309

MDPI

Access to resources Recommend Favorite